» Authors » Mathilde Ritter

Mathilde Ritter

Explore the profile of Mathilde Ritter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 167
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zehnpfennig L, Ritter M, Montagna G, Handschin T, Ling B, Oberhauser I, et al.
J Plast Reconstr Aesthet Surg . 2022 Sep; 75(11):4125-4132. PMID: 36153297
Purpose: Postoperative complications after breast cancer surgery may be associated with decreased quality of life. It remains unclear whether oncoplastic breast-conserving surgery or mastectomy with reconstruction lead to more postoperative...
2.
Ritter M, Oberhauser I, Montagna G, Zehnpfennig L, Schaefer K, Ling B, et al.
J Plast Reconstr Aesthet Surg . 2022 Jun; 75(9):3068-3077. PMID: 35732566
Background: This study aims to compare patient-reported outcomes (PROs) after different types of oncoplastic surgery (OPS) procedures and correlate the results with previously published normative data from women with no...
3.
Oberhauser I, Zeindler J, Ritter M, Levy J, Montagna G, Mechera R, et al.
Breast Care (Basel) . 2021 Nov; 16(5):452-460. PMID: 34720804
Background: The aim of this study was to compare the risk of complications and recurrence between oncoplastic and conventional breast surgery. Methods: This is a retrospective analysis of a consecutive...
4.
Fitzal F, Bolliger M, Dunkler D, Geroldinger A, Gambone L, Heil J, et al.
Ann Surg Oncol . 2021 Oct; 29(2):1061-1070. PMID: 34647202
Introduction: Recent data suggest that margins ≥2 mm after breast-conserving surgery may improve local control in invasive breast cancer (BC). By allowing large resection volumes, oncoplastic breast-conserving surgery (OBCII; Clough...
5.
Krol I, Schwab F, Carbone R, Ritter M, Picocci S, De Marni M, et al.
Br J Cancer . 2021 Mar; 125(1):23-27. PMID: 33762721
Circulating tumour cell (CTC) clusters have been proposed to be major players in the metastatic spread of breast cancer, particularly during advanced disease stages. Yet, it is unclear whether or...
6.
Montagna G, Tong Y, Ritter M, Levi J, Weber W, Chen X, et al.
Oncology . 2021 Mar; 99(6):359-364. PMID: 33735903
Background: Neoadjuvant chemotherapy (NAC) is increasingly used to treat node-positive (N+) breast cancer. Predictors of nodal pathological complete response (pCR) in Asian women are poorly described and there is variety...
7.
Dubsky P, Pinker K, Cardoso F, Montagna G, Ritter M, Denkert C, et al.
Lancet Oncol . 2021 Jan; 22(1):e18-e28. PMID: 33387500
Primary systemic therapy is increasingly used in the treatment of patients with early-stage breast cancer, but few guidelines specifically address optimal locoregional therapies. Therefore, we established an international consortium to...
8.
Weber W, Morrow M, de Boniface J, Pusic A, Montagna G, Kappos E, et al.
Lancet Oncol . 2020 Aug; 21(8):e375-e385. PMID: 32758475
The aims of the Oncoplastic Breast Consortium initiative were to identify important knowledge gaps in the field of oncoplastic breast-conserving surgery and nipple-sparing or skin-sparing mastectomy with immediate breast reconstruction,...
9.
Ritter M, Paradiso V, Widmer P, Garofoli A, Quagliata L, Eppenberger-Castori S, et al.
Clin Breast Cancer . 2020 Jul; 20(5):413-421.e1. PMID: 32650988
Introduction: The aim of this study was to assess the feasibility of cell-free DNA (cfDNA) extraction and circulating tumor DNA sequencing in 30-year-old serum samples. Materials And Methods: We evaluated...
10.
Montagna G, Ritter M, Weber W
Breast . 2019 Dec; 48 Suppl 1:S2-S6. PMID: 31839152
One of the most important news occurring in axillary surgery since the last St. Gallen Conference in 2017 was the publication of confirmatory long-term follow-up data from several large multicenter...